Partial orchiectomy and testis intratubular germ cell neoplasia: World literature review

Urology Annals

Volumn 3, Issue 3, 2011, Pages 115-118

  Bazzi, Wassim M ^a,b   Raheem, Omer A ^a   Stroup, Sean P ^a   Kane, Christopher J ^a   Derweesh, Ithaar H ^a   Downs, Tracy M ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Intratubular germ cell neoplasia; partial orchiectomy; testicular carcinoma in situ

Indexed keywords

ANDROGEN; BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; PLATINUM COMPLEX;

BILATERAL CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARCINOMA IN SITU; CELL FUNCTION; COLD ISCHEMIA; CONTRALATERAL TUMOR; DISSECTION; HUMAN; INTRATUBULAR GERM CELL NEOPLASIA; LEYDIG CELL; ORCHIECTOMY; PARTIAL BODY RADIATION; PARTIAL ORCHIECTOMY; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SUBFERTILITY; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TESTIS BIOPSY; TESTIS BLOOD FLOW; TESTIS CANCER; TESTIS CARCINOMA; TREATMENT INDICATION; TUMOR; TUMOR VOLUME;

EID: 80053062401     PISSN: 09747796     EISSN: 09747834     Source Type: Journal    
DOI: 10.4103/0974-7796.84948     Document Type: Review

References (35)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. Dieckmann KP, Skakkebaek NE. CIS of the testis: Review of biological and clinical features. Int J Cancer 1999;83:815-22.
3. Müller H, Skakkebaek NE. Risk of testicular cancer in Subfertile men: Case-control study. BMJ 1999;318:559-62. (Pubitemid 29188952)
4. Dieckmann K, Boeckmann W, Brosig W, Jonas D, Bauer HW. Bilateral Testicular Germ Cell Tumors: Report of nine cases and Review of the literature. Cancer 1986;57:1254-8. (Pubitemid 16166242)
5. Harland SJ, Cook PA, Fossa SD, Horwich A, Mead GM, Parkinson MC, et al. Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: Defining ahigh risk group. J Urol 1998;160:1353-7. (Pubitemid 29480515)
6. Heidenreich A, Hofmann R. Quality of life issues in the treatment of testicular cancer. World J Urol 1999;17:230-8.
7. Weissbach L. Organ Preserving Surgery of Malignant Germ Cell Tumors. J Urol 1995;153:90-3. (Pubitemid 24379805)
8. Heidenreich A, Bonfig R, Derschum W, Von Vietsch H, Wilbert D. A conservative approach to bilateral testicular germ cell tumors. J Urol 1995;153:10-3. (Pubitemid 24379785)
9. Heidenreich A, Holtl W, Albrecht W, Pont J, Engelmann UH. Testis-preserving surgery in bilateral testicular germ cell tumors. Br J Urol 1997;79:253-7.
10. Heidenreich A, Weibbach L, Holtl W, Albers P, Kliesch S, Kohrmann K, et al. Organ Sparing Surgery for Malignant Germ Cell Tumor of the Testis. J Urol 2001;166:2161-5. (Pubitemid 33065246)
11. Richie JP. Simultaneous bilateral testis tumors with unorthodox management. World J Urol 1984;2:74.
12. Kirkali Z, Tuzel E, Canda AE, Mungan MU. Testis sparing surgery for the treatment of a sequential bilateral testicular germ cell tumor. Int J Urol 2001;8:710-2. (Pubitemid 34094016)
13. Houlgatte A, De La Taille A, Fournier R, Goluboff ET, Camporo P, Houdelette P. Paternity in a patient with seminoma and carcinoma in situ in a solitary testis treated by partial orchidectomy. BJU Int 1999; 84:374-5. (Pubitemid 29376196)
14. Hughes P. Partial Orchidectomy for Malignancy with Consideration of carcinoma in situ. ANZ J Surg 2006;76:92-4.
15. Skakkebaek N. Possible Carcinoma-in-situ of the Testis. Lancet 1972;2:516-7.
16. Sonneveld DJ, Schraffordt Koops S, Sleijfer D, Hoekstra HJ. Bilateral Testicular Germ Cell Tumours in Patients with Initial Stage I Disease: Prevalence and Prognosis-A Single Centre's 30 Years' Experience. Eur J Cancer 1998;34:1363-7. (Pubitemid 28370927)
17. Dieckmann KP, Pichlmeier U. Clinical epidemiology of testicular germ cell tumors. World J Urol 2004;22:2-14. (Pubitemid 41406567)
18. Giwercman A, Bruun E, Frimodt-Moller C, Skakkebaek NE. Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. J Urol 1989;142:998-1001.
19. Von Der Maase H, Rorth M, Walbom-Jorgensen S, Sorensen B, Christophersen IS, Hald T, et al. Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: Study of 27 cases in 500 patients. Br Med J (Clin Res Ed) 1986;293:1398-401. (Pubitemid 17190289)
20. Lee E, Holzbeierlein J. Management of the contralateral testicle in patients with unilateral testicular cancer. World J Urol 2009;27:421-6.
21. Von der Maase H, Giwercman A, Skakkebaek NE. Radiation treatment of carcinoma-in-situ of testis. Lancet 1986;1:624-5. (Pubitemid 16138419)
22. Giwercman A, Von Der Maase H, Berthelsen JG, Rorth M, Bertelsen A, Skakkebaek NE. Localized Irradiation of Testes with CIS: Effects on Leydig Cell Function and Eradication of Malignant Germ Cells in 20 Patients. J Clin Endocrinol Metab 1991;73:596-603. (Pubitemid 21921914)
23. Petersen P, Giwercman A, Daugaard G, Rorth M, Petersen J, Skakkebaek N, et al. Effect of Graded Testicular Doses of Radiotherapy in Patients Treated for Carcinoma-in-situ in the Testis. J Clin Oncol 2002;20:1537-43. (Pubitemid 34260533)
24. Dieckmann KP, Lauke H, Michl U, Winter E, Loy V. Testicular Germ Cell Cancer despite Previous Local Radiotherapy to the Testis. Eur Urol 2002;41:643-50. (Pubitemid 35333922)
25. Dotsch M, Brauers A, Buttner R, Nolte-Ernsting C, Eble M, Jakse G. Malignant Germ Cell Tumor of the Contralateral Testis after Radiotherapy for Testicular Intraepithelial Neoplasia. J Urol 2000;164:452-3. (Pubitemid 30481954)
26. Dieckmann KP, Loy V. Prevalence of Contralateral Testicular Intraepithelial Neoplasia in Patients with Testicular Germ Cell Neoplasms. J Clin Oncol 1996;14:3126-32. (Pubitemid 26408806)
27. Dieckmann KP, Loy V. False-negative biopsies for the diagnosis of testicular intraepithelial neoplasia (TIN)-an update. Eur Urol 2003;43:516-21. (Pubitemid 36528438)
28. Herr HW, Sheinfeld J. Is Biopsy of the Contralateral Testis Necessary in Patients with Germ Cell Tumors? J Urol 1997;158:1331-4. (Pubitemid 27391190)
29. Fossa SD, Chen J, Schonfeld SJ, McGlynn KA, McMaster ML, Gail MH, et al. Risk of Contralateral Testicular Cancer: A Population-based study of 29,515 U.S. Men. J Natl Cancer Inst 2005;97:1056-66. (Pubitemid 41417922)
30. Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, et al. European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I. Eur Urol 2008;53:478-96.
31. Montie JE. Carcinoma in situ of the testis and bilateral carcinoma. Urol Clin North Am 1993;20:127-32. (Pubitemid 23065511)
32. Klatte T, De Martino M, Arensmeier K, Reiher F, Allhoff E, Klatte D. Management and outcome of bilateral testicular germ cell tumors: A 25-year single center experience. Int J Urol 2008;15:821-6.
33. Holzbeierlein J, Sogani P, Sheinfeld J. Histology and Clinical Outcomes in patients with Bilateral Testicular Germ Cell Tumors: The Memorial Sloan Kettering Cancer Center Experience 1950 to 2001. J Urol 2003;169:2122-5. (Pubitemid 36576731)
34. Kleinschmidt K, Dieckmann KP, Georgiew A, Loy V, Weissbach L. Chemotherapy is of Limited Efficacy in the Control of Contralateral Testicular Intraepithelial Neoplasia in Patients with Testicular Germ Cell Cancer. Oncology 2009;77:33-9.
35. Van Basten JP, Hoekstra HJ, Van Driel MF, Sleijfer DT, Droste JH, Schraffordt Koops H. Cisplatin-Based Chemotherapy Changes the Incidence of Bilateral Testicular Cancer. Ann Surg Oncol 1997;4:342-8. (Pubitemid 127725239)